Gossamer Bio launches with $100 mln in funding
San Diego-based biopharmaceutical company Gossamer Bio has launched and announced it has raised $100 million in funding. The financing includes seed funding from founding investor Omega Funds and a Series A round co-led by Omega and ARCH Venture Partners.
5 January 2018•1 min read
